---
title: "Cann Group seeks ASX quotation for over 13 million new shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284866456.md"
description: "Cann Group Limited has applied to the ASX for quotation of 13,163,102 new fully paid ordinary shares, set to be issued on May 1, 2026. This move, resulting from the exercise of existing options, aims to expand the company's quoted share capital, potentially affecting its capital structure and trading liquidity. While existing shareholders may face dilution, the increase in quoted shares could enhance market depth and support future capital-raising efforts as Cann Group continues its medicinal cannabis operations."
datetime: "2026-05-01T04:58:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284866456.md)
  - [en](https://longbridge.com/en/news/284866456.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284866456.md)
generator: "portal-rs"
---

# Cann Group seeks ASX quotation for over 13 million new shares

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The latest announcement is out from Cann Group ( (AU:CAN) ).

Cann Group Limited has applied to the ASX for quotation of 13,163,102 new fully paid ordinary shares, with an issue date of 1 May 2026. The additional securities, arising from the exercise or conversion of existing options or other convertible instruments, will expand the company’s quoted share capital and may influence its capital structure and trading liquidity once admitted to quotation.

The move reflects the company’s ongoing use of equity-linked instruments to fund operations or incentivise stakeholders, consolidating these into ordinary stock on the market. For existing shareholders, the enlarged pool of quoted shares may have dilution implications but could also support improved market depth and facilitate future capital-raising flexibility as Cann Group advances its medicinal cannabis activities.

**More about Cann Group**

Cann Group Limited is an Australian-listed company in the medicinal cannabis sector. The group focuses on cultivating, producing and supplying cannabis-based products, serving domestic and potentially export pharmaceutical and therapeutic markets under the ticker CAN on the ASX.

**Technical Sentiment Signal:** Sell

**Current Market Cap:** A$8.87M

See more data about CAN stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [CAN.AU](https://longbridge.com/en/quote/CAN.AU.md)

## Related News & Research

- [AMA Group Seeks ASX Quotation for 757,685 New Ordinary Shares](https://longbridge.com/en/news/297842777.md)
- [Rubicon Water issues new shares and lodges cleansing notice to ASX](https://longbridge.com/en/news/297599873.md)
- [India's NSE eyes Sep 21-week listing after regulator clears IPO, sources say](https://longbridge.com/en/news/298101548.md)
- [The Calmer Co. Details ASX Governance Compliance in Appendix 4G Filing](https://longbridge.com/en/news/297454626.md)
- [Charoen Pokphand Indonesia says unaware of material information behind CPIN share volatility](https://longbridge.com/en/news/297737904.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**